drugset
drugset / Trial / NCT02689258

Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery

NCT02689258 ↗

Phase 2 Completed 277 enrolled Heron Therapeutics
RandomizedParallel-groupDouble-blindOther

Summary

A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery

Timeline

Start
2016-02-23
Primary completion
2017-03
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 100 mg Other
Subject HTX-002 Unknown 400 mg —
Subject HTX-011A Unknown 200 mg Other
Subject HTX-011B Unknown 200 mg Other
Subject HTX-011B Unknown 300 mg Other
Subject HTX-011B Unknown 400 mg Other
Subject HTX-011B Unknown 600 mg Other

Indications

No indication recorded.